Your browser doesn't support javascript.
loading
Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease.
Lomas, James; Asaria, Miqdad; Bojke, Laura; Gale, Chris P; Richardson, Gerry; Walker, Simon.
Affiliation
  • Lomas J; Centre for Health Economics, University of York, York, YO10 5DD, UK. james.lomas@york.ac.uk.
  • Asaria M; Centre for Health Economics, University of York, York, YO10 5DD, UK.
  • Bojke L; Centre for Health Economics, University of York, York, YO10 5DD, UK.
  • Gale CP; MRC Bioinformatics Centre, LICAMM, University of Leeds, Leeds, UK.
  • Richardson G; Centre for Health Economics, University of York, York, YO10 5DD, UK.
  • Walker S; Centre for Health Economics, University of York, York, YO10 5DD, UK.
Pharmacoecon Open ; 2(4): 403-413, 2018 Dec.
Article in En | MEDLINE | ID: mdl-29446055

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation / Health_technology_assessment Aspects: Patient_preference Language: En Journal: Pharmacoecon Open Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation / Health_technology_assessment Aspects: Patient_preference Language: En Journal: Pharmacoecon Open Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland